Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,745
Total Claims
$1.2M
Drug Cost
623
Beneficiaries
$1,990
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-10%
Opioid rate vs peers
2.0% vs 2.2% avg
+41%
Cost per patient vs peers
$1,990 vs $1,411 avg
+38%
Brand preference vs peers
14.7% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.0%
Opioid Rate
176
Opioid Claims
$1,679
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,263 claims · $1.1M
Generic: 7,356 claims · $167K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 91 | $138K |
| Semaglutide | 102 | $112K |
| Dulaglutide | 82 | $97K |
| Apixaban | 89 | $84K |
| Tirzepatide | 64 | $75K |
| Rivaroxaban | 41 | $58K |
| Dapagliflozin Propanediol | 19 | $35K |
| Sitagliptin Phos/Metformin Hcl | 18 | $32K |
| Mirabegron | 22 | $25K |
| Budesonide/Formoterol Fumarate | 39 | $23K |
| Liraglutide | 14 | $22K |
| Vibegron | 18 | $21K |
| Linaclotide | 29 | $21K |
| Linagliptin | 11 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 26 | $18K |
Prescribing Profile
Patient Profile
76
Avg Age
53%
Female
1.16
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About